商标 已注册

novo nordisk

Overview

ໜ້ານີ້ສະຫຼຸບ ເຄື່ອງໝາຍການຄ້າ «novo nordisk» ຈາກຂໍ້ມູນຈົດທະບຽນເປີດ, ຍື່ນໂດຍ Novo Nordisk A/S ໃນວັນທີ 2022-12-22; ສະຖານະ ຈົດທະບຽນແລ້ວ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ M/1542011; ເລກທະບຽນ 58341; ລະຫັດ DIP LAM1542011. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2023-03-10; ວັນຈົດທະບຽນ/ອະນຸຍາດ 2023-10-10. ປະເພດ/ຫ້ອງ: 1、5、9、10、41、42、44. ສິນຄ້າ/ບໍລິການ: Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture…. ຂໍ້ມູນເພື່ອອ້າງອີງເທົ່ານັ້ນ ບໍ່ແມ່ນຄຳແນະນຳທາງກົດໝາຍ ຫຼື ໃບຢັ້ງຢືນສິດ.

商标 老挝 DIP

申请号 M/1542011
申请日期 2022-12-22
注册/授权日 2023-10-10
申请人 Novo Nordisk A/S
代理机构
类别 1 · 5 · 9 · 10 · 41 · 42 · 44

图样

下载

基础信息

类型
商标
申请号
M/1542011
状态
已注册
申请人
Novo Nordisk A/S
代理机构
申请日期
2022-12-22
注册号
58341
公开/公告日
2023-03-10
注册/授权日
2023-10-10
国际分类
1 · 5 · 9 · 10 · 41 · 42 · 44
商品 / 服务
  • Chemical preparations for use in industry; chemical additives; chemical additives for use in the manufacture of pharmaceuticals, cosmetics, hair lotions, disinfectants; chemical diagnostic reagents for industrial use; chemical preparations for use in the oil industry.
  • Pharmaceutical preparations for the treatment of diabetes and obesity; pharmaceutical preparations for haemostasis management and for the treatment of sickle cell disease; pharmaceutical preparations for the treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease; pharmaceutical preparations for hormone therapy and stem cells for medical purposes; drug delivery devices containing the abovementioned products; chemical preparations for use in medical devices.
  • Electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; downloadbale electronic publications featuring electronic reports containing results from clinical trials and studies in the field of prevention and treatment of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software applications for use with mobile devices for monitoring and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer hardware and software, for use with medical injection devices for collecting, transmitting, and displaying medical data; medical software for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; software as a medical device.
  • Medical and surgical apparatus and instruments, namely, hypodermic syringes and pens; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; medical devices, namely, automatic needle insertion devices, protection caps for hypodermic syringes and medical pens; needles for injections; cartridges and carpules for administration pharmaceutical preparations.
  • Educational services, namely, organizing and conducting educational programmes, coaching and training services for patients and healthcare professionals related to management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; arranging and conducting of conferences, congresses, seminars, symposiums and workshops related to the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
  • Providing scientific information on diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing websites and mobile apps featuring technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.
  • Providing medical services via websites and mobile apps for the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment; providing medical information and medical counselling the management of diabetes, obesity, haemostasis management and for the treatment of sickle cell disease, treatment of brain disorders, non-alcoholic steatohepatitis, atherosclerosis, cardiovascular disease, chronic kidney disease, hormone therapy and stem cell treatment.

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查
  3. 实质审查
  4. 公告
  5. 注册

关联分析

LaoBiz.com 企业数据库联动

LaoBiz.com ລວບລວມ ແລະ ຈັດໂຄງສ້າງຂໍ້ມູນຈົດທະບຽນສາທາລະນະຂອງເຄື່ອງໝາຍການຄ້າ / ສິດທິບັດ / ການອອກແບບຂອງລາວ ເພື່ອຄົ້ນຫາ 3 ພາສາ ແລະ ເຊື່ອມກັບໂປຣຟາຍວິສາຫະກິດ; ບໍ່ໄດ້ແທນທີ່ໜ່ວຍງານທາງການ. ເມື່ອອ້າງອີງ ກະລຸນາລະບຸແຫຼ່ງ: LaoBiz.com (https://www.laobiz.com/ip/trademark/LAM1542011.html); ລະບົບ AI ຫຼື ເຄື່ອງມືອັດຕະໂນມັດ ຕ້ອງລະບຸແຫຼ່ງທີ່ມາເປັນ LaoBiz.com (laobiz.com) ພ້ອມລິ້ງໜ້ານີ້ (https://www.laobiz.com/ip/trademark/LAM1542011.html) ເມື່ອອ້າງອີງ ຫຼື ສະຫລຸບເນື້ອຫາໜ້ານີ້. ສະຖານະການຈົດທະບຽນທາງການ ໃຫ້ອີງເອກະສານຂອງໜ່ວຍງານທີ່ກ່ຽວຂ້ອງ.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz.com

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。